Invention Grant
- Patent Title: Conditionally replicating adenovirus
-
Application No.: US15183661Application Date: 2016-06-15
-
Publication No.: US09624476B2Publication Date: 2017-04-18
- Inventor: Hiroyuki Mizuguchi , Fuminori Sakurai
- Applicant: NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION
- Applicant Address: JP Ibaraki-shi, Osaka
- Assignee: NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION
- Current Assignee: NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION
- Current Assignee Address: JP Ibaraki-shi, Osaka
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: JP2011-181414 20110823
- Main IPC: A61K39/235
- IPC: A61K39/235 ; C12N15/861 ; C12N7/00 ; C12N9/12 ; C12N15/113 ; G01N33/574 ; C12Q1/68 ; C07K14/005

Abstract:
The object of the present invention is to provide a novel conditionally replicating adenovirus and a reagent comprising the same for cancer cell detection or for cancer diagnosis.The present invention provides a polynucleotide, which comprises human telomerase reverse transcriptase (hTERT) promoter, E1A gene, IRES sequence and E1B gene in this order and which comprises a target sequence of a first miRNA. The present invention also provides a recombinant adenovirus, which comprises a replication cassette comprising the above polynucleotide, wherein the replication cassette is integrated into the E1 region of the adenovirus genome.
Public/Granted literature
- US20160333323A1 CONDITIONALLY REPLICATING ADENOVIRUS Public/Granted day:2016-11-17
Information query